With a growing number of patients on ticagrelor therapy after stent implantation, we observe many cases of side effects of the drug, mostly dyspnoea and bradycardia. In our article we present 2 patients, in which the symptoms were particularly severe. Then we describe possible mechanisms of these complications, explain how to carry out differential diagnosis, discuss when to switch ticagrelor to other antiplatelet drug and finally we present the way to deal with the symptoms.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550933 | PMC |
| http://dx.doi.org/10.1177/1179547620956634 | DOI Listing |
Publication Analysis
Top Keywords
differential diagnosis
8
ticagrelor-related severe
4
severe dyspnoea
4
dyspnoea mechanisms
4
mechanisms characteristic
4
characteristic features
4
features differential
4
diagnosis treatment
4
treatment growing
4
growing number
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!